pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,499
stories
Jul 9, 26
Ipsen succeeds in migraine trials; Tarsus buys iRenix for $75M upfront
endpoints
Jul 9, 26
STAT+: 931 days. The drug approval scandal hiding in plain sight
stat
Jul 8, 26
Bryan Johnson’s chronic disease is notoriously difficult to diagnose
stat
Jul 8, 26
Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
stat
Jul 8, 26
Novartis cuts New Jersey jobs; OTR, LG Chem explore China cancer drugs
endpoints
Jul 8, 26
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
stat
Jul 8, 26
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
biopharma dive
Jul 6, 26
STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms
stat
Jul 6, 26
Bristol Myers details Krazati confirmatory study failure in colorectal cancer
endpoints
Jul 6, 26
Roche aims to bolster breast cancer pipeline with early-stage Astex deal
endpoints
Jul 6, 26
Gene editing developer Scribe plots an IPO
biopharma dive
Jul 6, 26
Novartis to acquire ADC developer in a deal worth up to $1.5B
biopharma dive
Jul 6, 26
STAT+: Four major biotech updates to catch up on
stat
Jul 6, 26
Cancer, immune drugmakers dominate VC funding so far in 2026
biopharma dive
Jul 6, 26
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
stat
Jul 6, 26
The race for an Ebola therapy begins
stat
Jul 6, 26
Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platform
endpoints
Jul 6, 26
STAT+: GOP lawmakers push Trump’s FDA to make sure clinical trials are diverse
stat
Jul 6, 26
STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
stat
Jul 2, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Jul 2, 26
STAT+: What does DeGette’s loss mean for pharma?
stat
Jul 2, 26
Revolution Medicines shares promising data around KRAS drug combination
endpoints
Jul 2, 26
Roche KRAS drug succeeds in head-to-head lung cancer study
biopharma dive
Jul 2, 26
STAT+: Roche drug sets new standard for KRAS-driven lung cancer
stat
Jul 2, 26
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
stat
Jul 2, 26
STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug
stat
Jul 2, 26
STAT+: More frequent, more intense, and longer heat waves pose health risks for Americans
stat
Jul 2, 26
Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 study
endpoints
Jul 2, 26
STAT+: Halfway into the year, biotech is booming
stat
Jul 2, 26
Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists
stat
← prev
page 33 of 50
next →
